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Iatrogenic Femoral Artery Pseudo
AneurysmsTo the Editor:
Despite increasing use of radial artery for percutaneous
interventions, femoral artery is still commonly used for
both diagnostic and therapeutic interventions. Decreased
size of sheats is the principal mechanism underlying
reduced complication rates for femoral artery interven-
tions. The most common accesserelated complications af-
ter femoral artery interventions are pseudoaneurysms,
hematoma, arteriovenous fistula, and retroperitoneal
hemorrhage.
Pseudoaneurysms are frequently due to lower punc-
ture below the common femoral artery bifurcation.
The frequency is reported between 0.2% after diagnostic
procedures and nearly 8% after interventional
procedures.1
In our institution, we perform nearly 2,400 diagnostic
and interventional procedures using femoral access. In the
last 2 years, we experienced 16 cases of femoral pseudoa-
neurysms following femoral access. This makes nearly
0.003%. We did not perform routine ultrasonography,
and thus, this ratio is not comparable to other studies.
What we would like to underscore is 15 out of 16 cases
(93.7%) were successfully treated with ultrasound-
guided compression and only 1 patient underwent sur-
gery who had a 25-mm pseudoaneurysm. Minimal and
maximal duration of compression was 15 min and 3 hr,
respectively. Before compression, intravenous line was
established, skin was sterilized, and topical lidocaine was
applied in order to reduce pain.
Ultrasound-guided thrombin injection is another alter-
native method for treatment of femoral artery pseudoa-
neurysms. By using both manual compression and
ultrasound-guided thrombin injection, Dzijan-Horn
et al.2 reported a success rate of 97.2%. In their series,
only 10 patients out of 432 pseudoaneurysm cases
(2.3%) needed surgical intervention.
In conclusion, ultrasound-guided compression is still
an effective method for the treatment of iatrogenic
femoral artery pseudoaneurysms.
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N-Terminal Pro-Brain Natriuretic
Peptide Levels after Endovascular
Repair of Descending Thoracic AortaDear Editor,
We readwith great interest a recent article byMoulaka-
kis et al.1 entitled ‘‘Changes in arterial stiffness and N-ter-
minal pro-brain natriuretic peptide levels after
endovascular repair of descending thoracic aorta.’’ In this
prospective study, theauthors aimed to investigate changes
in arterial stiffness and N-terminal pro-brain natriuretic
peptide (NT-proBNP) levels in patients undergoing endo-
vascular repair of descending thoracic aorta. The authors
measured serum levels of NT-proBNP preoperatively,
24 hr, 48 hr, and 6 months postoperatively. In addition,
they evaluated pulse wave velocity (PWV) before and
6 months after endovascular repair of descending thoracic
aorta. As stated in statistical analysis section and abstract
of the article, the authors used 1-way analysis of variance
(ANOVA) to assess alteration in PWV (from baseline to
6 months) and NT-proBNP (between 4 phases of measure-
ment). Indeed, they evaluated somenumerical variables in
1 sample of patients during different time points including
baseline, 24 hr, 48 hr, and 6 months after endovascular
repair. Since they investigated 1 same sample of patients
during different time points (i.e., baseline, 24 hr, 48 hr,
and 6 months), their measurements are completely
dependent.2e4 One-way ANOVA is used for comparison
of themeansofmore than2 independent groups.5e8There-
fore, after assessment of the normal distribution of studied
quantitative variables including NT-proBNP and PWV, the
authors must use repeated-measures ANOVA or Friedman
test for comparison of the means of each variable at base-
line, 24 hr, 48 hr, and 6 months after endovascular
repair.9,10 Furthermore, they must use Wilcoxon test and
paired t test for comparison of NT-proBNP and PWV be-
tween 2 time points of measurement.
Abolfazl Zahedi1
Milad Ebrahimi2
1Student Research Committee, Kashan University of Medical
Sciences, Kashan, Iran
2Department of Immunology, School of Medicine, Shahed
University, Tehran, Iran
E-mail: milad.labsc@yahoo.com
REFERENCES
1. Moulakakis KG, Kadoglou NP, Antonopoulos CN, et al.
Changes in arterial stiffness and N-terminal pro-brain
322 Correspondence Annals of Vascular Surgerynatriuretic peptide levels after endovascular repair of
descending thoracic aorta. Ann Vasc Surg 2017;38:220e6.
2. Farrokhi M, Peykanpour F. Statistical comments on ‘‘sali-
vary iron (Fe) ion levels, serum markers of anemia and
caries activity in pregnant women’’. Rev Bras Ginecol Obstet
2017;39:583.
3. Farrokhi M, Masoudifar A, Peykanpour F. Interleukin 17
and 10 in relapsing remitting multiple sclerosis. J Neurol
Sci 2017;378:63.
4. Farrokhi M, Shirian N. Statistical comments on ‘‘no seasonal
variation in physical activity of Han Chinese living in Bei-
jing’’. Int J Behav Nutr Phys Act 2017;14:151.
5. Farrokhi M, Peykanpour F. Vascular endothelial growth
factoreloaded bioresorbable delivery system for pulp regen-
eration. J Endod 2017;43:1414.
6. Farrokhi M. Sema3A and multiple sclerosis. Gene 2017;41.7. Farrokhi M, Arjaki D. Statistical comments on ‘‘cytokine
and chemokine profiles in patients with neuromyelitis
optica spectrum disorder’’. Neuroimmunomodulation 2017;
24:120.
8. Gaddis ML. Statistical methodology: IV. Analysis of variance,
analysis of Co variance, and multivariate analysis of vari-
ance. Acad Emerg Med 1998;5:258e65.
9. Farrokhi M. Reply to: statistical support for Sema3A and
multiple sclerosis. Gene 2017;631:52.
10. Farrokhi M, Amani-Beni A. Statistical comments on‘‘ assess-
ment of musculoskeletal strength and levels of fatigue dur-
ing different phases of menstrual cycle in young adults’’. J
Clin Diagn Res 2017;11:CL01.http://dx.doi.org/10.1016/j.avsg.2018.01.066
